Inside Seattle Clinic That Treats Tech Addiction Like Heroin
A Seattle-area clinic is adopting a stark, device-free recovery model for tech addiction, with detox programs lasting...
Compare Glide Path and Equal Weight strategies to understand which fits your retirement goals. Learn key differences, risks, and practical steps to apply in your portfolio.
26,443 articlesA Seattle-area clinic is adopting a stark, device-free recovery model for tech addiction, with detox programs lasting...
Vanguard’s FTSE Developed Markets ETF has posted stronger gains than the S&P 500 in 2026, drawing renewed investor in...
Investors and economists are linking AI skepticism to job security and wage growth, not just beliefs about technology...
Energy Transfer is shifting from a pure yield play to a growth story as key midstream projects advance. This long-for...
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
When a company's CFO sells stock, investors watch closely. This analysis dives into Commvault Systems' sold over trad...
The AI memory boom has traders watching the Roundhill Memory ETF. With a potential SK Hynix ADR list around July 10, ...
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Oracle's backlog surge and accelerating AI infrastructure growth are fueling a heated debate on whether the stock is ...
A healthy 65-year-old with a family history of long life confronts Social Security timing beyond the classic break-ev...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...